| Apr. 1999 |
Founded in Hodogaya, Yokohama. |
| Aug. 1999 |
Marketed the first made-in-Japan DNA chip “Yeast Chip ver. 1.0.” |
| Dec. 2001 |
Moved headquarter to Science Frontier District, Tsurumi-ku, Yokohama. |
| Mar. 2004 |
Announced IPO on Tokyo Stock Exchange MOTHERS (Capital increased to 600 million Japanese Yen). |
| Nov. 2006 |
Formed strategic alliance on microarray business with Agilent Technologies Inc., USA. |
| May. 2007 |
Started new product services “ConPath Chip” and “ConPath Navigator”. |
| Aug. 2007 |
Marketed “Hyb-Teacher”, an educational microarray genotyping kit for students. |
| Nov. 2007 |
Received 24th Industrial Technology Development Incentive Award from Kanagawa Prefecture for development of “Probe Bank”. |
| Mar. 2008 |
Started Clinical Trial using “RNA Check” to assess the efficacy of DMARD's (Disease Modifying Anti-Rheumatic Drugs). |
| Mar. 2008 |
Started service of “Mamma Print”, a risk assessment test on prognosis of Breast Cancer. |
| Apr. 2009 |
Accredited with Privacy Mark. |
| Mar. 2011 |
Marketed “iCIS-crdb”, a gene expression data service for clinical research. |
| Apr. 2011 |
Marketed “iRIS”, a rheumatoid arthritis electronic survey system in clinical settings. |
| Dec. 2011 |
Marketed “TBONE EX KIT”, a DNA extraction kit for hard tissue such as tooth and bone. |
| Oct. 2013 |
Formed strategic alliance with Agilent Technologies Inc., USA on Next Generation Sequence analysis service. |
| Aug. 2014 |
Transferred to the 2nd Section of the Tokyo Stock Exchange. |
| Nov. 2014 |
Signed capital and business alliance agreement with Enplas Corporation (Capital increased to 1.4 billion Japanese yen). |
| Mar. 2015 |
Original research paper published on identification of miRNA that regulates tumorigenesis of glioma, in collaboration with Ehime University Graduate School of Medicine and Hokkaido University. |
| Apr. 2015 |
Launched liquid biopsy companion diagnostic test DiVA-EGFR Check to detect rare mutants in plasma cell-free DNA of lung cancer patients. |
| Apr. 2015 |
Developed and published a set of external RNA standards and control probes, which enable multi-platform calibration and data validation among microarray, qPCR and NGS (part of a JMAC (Japan Multiplex bio-Analysis Consortium) project). |
| May. 2015 |
Patent awarded for Biomarker and Method used for Determining Rheumatoid Arthritis Disease Activity (Patent Number: 5676777). |
